Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,550.00
+30.00 (0.54%)
At close: Sep 11, 2026

Pharos iBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
71,850121,56298,001191,588--
Market Cap Growth
-7.81%24.04%-48.85%---
Enterprise Value
58,413112,92580,945164,210--
Last Close Price
5550.009390.007570.0014830.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
7.398.735.276.76--
P/TBV Ratio
7.698.975.396.79--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.910.570.010.010.02-0.04
Net Debt / Equity Ratio
-1.38-1.30-0.83-0.89-0.831.47
Net Debt / EBITDA Ratio
1.381.691.322.671.472.88
Net Debt / FCF Ratio
1.932.161.553.051.732.74
Asset Turnover
----0.010.00
Quick Ratio
27.4018.7116.2521.1516.060.56
Current Ratio
28.3318.9616.7021.5716.530.57
Return on Equity (ROE)
-83.69%-66.11%-44.97%-38.50%-1825.61%-
Return on Assets (ROA)
-33.03%-29.06%-31.94%-26.12%-28.73%-23.78%
Return on Capital Employed (ROCE)
-41.60%-40.40%-67.50%-35.50%-59.80%55.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.21%-8.85%-10.78%-4.62%--
FCF Yield
-9.72%-6.88%-10.21%-4.31%--
Buyback Yield / Dilution
-0.03%-0.16%-6.81%-36.26%-53.03%-2.65%